We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
Cap. Flow
-$90.2M
Cap. Flow %
-14.22%
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127

Top Buys

Rank Stock Value
1
LPSN icon
LivePerson
LPSN
+$4.19M
2
NVTR
Nuvectra Corporation Common Stock
NVTR
+$4.14M
3
TBCH
Turtle Beach Corp
TBCH
+$4.13M
4
BEAT
BioTelemetry, Inc.
BEAT
+$4.07M
5
TCMD icon
Tactile Systems Technology
TCMD
+$4.05M

Top Sells

Rank Stock Value
1
NKTR icon
Nektar Therapeutics
NKTR
+$6.81M
2
CUTR
Cutera, Inc.
CUTR
+$4.92M
3
VCEL icon
Vericel Corp
VCEL
+$4.77M
4
ESPR
Esperion Therapeutics
ESPR
+$4.75M
5
INST
Instructure, Inc.
INST
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 27.66%
2 Technology 24.9%
3 Consumer Discretionary 14.4%
4 Industrials 10.81%
5 Financials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLPH
276
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$562K 0.09%
15,486
– –
ONCT
277
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$560K 0.09%
261
– –
APVO icon
278
Aptevo Therapeutics
APVO
$5.12M
– –
0
– –
FSBW icon
279
FS Bancorp
FSBW
$319M
$546K 0.09%
17,278
-5,376
-24% -$156K
RICK icon
280
RCI Hospitality Holdings
RICK
$192M
$541K 0.09%
17,101
-10,288
-38% -$309K
VCEL icon
281
Vericel Corp
VCEL
$2.35B
$533K 0.08%
54,964
-383,252
-87% -$4.77M
IOTS
282
DELISTED
Adesto Technologies Corp
IOTS
$523K 0.08%
62,219
– –
FLL icon
283
Full House Resorts
FLL
$80.1M
$327K 0.05%
98,091
-72,584
-43% -$240K
FC icon
284
Franklin Covey
FC
$242M
$326K 0.05%
13,294
-12,331
-48% -$332K
JASN
285
DELISTED
Jason Industries, Inc.
JASN
$301K 0.05%
129,900
-76,681
-37% -$222K
LRMR icon
286
Larimar Therapeutics
LRMR
$397M
$232K 0.04%
+1,887
New +$160K
ALG icon
287
Alamo Group
ALG
$1.94B
– –
-12,268
Closed -$1.35M
ANAB icon
288
AnaptysBio
ANAB
$1.58B
– –
-17,023
Closed -$1.77M
ANF icon
289
Abercrombie & Fitch
ANF
$4.42B
– –
-37,240
Closed -$902K
APPS icon
290
Digital Turbine
APPS
$975M
– –
-663,672
Closed -$1.33M
EFOR
291
Everforth Inc
EFOR
$1.17B
– –
-46,247
Closed -$3.79M
ASMB icon
292
Assembly Biosciences
ASMB
$498M
– –
-2,695
Closed -$1.59M
BL icon
293
BlackLine
BL
$1.84B
– –
-63,558
Closed -$2.49M
BLBD icon
294
Blue Bird Corp
BLBD
$2.35B
– –
-45,734
Closed -$1.08M
BLDR icon
295
Builders FirstSource
BLDR
$7.15B
– –
-101,458
Closed -$2.01M
BLUE
296
DELISTED
bluebird bio
BLUE
– –
-895
Closed -$1.98M
BPMC
297
DELISTED
Blueprint Medicines
BPMC
– –
-22,862
Closed -$2.1M
BWXT icon
298
BWX Technologies
BWXT
$15.5B
– –
-43,470
Closed -$2.76M
CLSD
299
DELISTED
Clearside Biomedical
CLSD
– –
-19,941
Closed -$3.21M
COLL icon
300
Collegium Pharmaceutical
COLL
$1.15B
– –
-148,629
Closed -$3.8M
10 11
12
13 14

Similar funds

NEPWA
New England Private Wealth Advisors Wellesley, Massachusetts $866M AUM 15.25% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
RB
Rodgers Brothers Harmony, Pennsylvania $866M AUM 30.05% 1-Year Est. Return
BGC
Blue Grotto Capital Atlanta, Georgia $868M AUM 56.95% 1-Year Est. Return
ICCFIA
IDG China Capital Fund III Associates Central Hong Kong, China $868M AUM 24.3% 1-Year Est. Return

EAM Investors's Q2 2018 Portfolio in Review

As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.

  • EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
  • EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
  • EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
  • EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
  • EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
  • EAM Investors opened 130 new positions and closed 127 in Q2 2018.
  • EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.

Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.